J. Hagan Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$490K Hold
1,268
0.23% 47
2026
Q1
$371K Hold
1,268
0.2% 52
2025
Q4
$444K Sell
1,268
-50
-4% -$16.9K 0.25% 52
2025
Q3
$426K Buy
1,318
+105
+9% +$32.7K 0.26% 57
2025
Q2
$335K Sell
1,213
-55
-4% -$22.1K 0.23% 59
2025
Q1
$468K Buy
+1,268
New +$509K 0.38% 37

Other funds holding ELV

J. Hagan Capital's ELV Position: Q2 2026 in Review

J. Hagan Capital held its Elevance Health (ELV) position steady in Q2 2026 at 1,268 shares worth $490K. The position accounts for 0.23% of the portfolio, ranked #47.

J. Hagan Capital first reported a position in ELV in Q1 2025 and has held it in 6 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • J. Hagan Capital held 1,268 shares of Elevance Health worth $490K as of Q2 2026.
  • J. Hagan Capital left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.23% of J. Hagan Capital's portfolio in Q2 2026, its #47 holding.
  • J. Hagan Capital first reported a position in Elevance Health in Q1 2025 and has held it in 6 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on J. Hagan Capital's 13F filing for Q2 2026, filed 14 Aug 2026.